Wataru Kitamura, Keiko Fujii, Mitsuru Tsuge, Toshiharu Mitsuhashi, Hiroki Kobayashi, Chihiro Kamoi, Akira Yamamoto, Takumi Kondo, Keisuke Seike, Hideaki Fujiwara, et al. A randomized controlled trial of conventional GVHD prophylaxis with or without teprenone for the prevention of severe acute GVHD. Annals of hematology. 2025
Wataru Kitamura, Nobuharu Fujii, Chihiro Kamoi, Toshiki Terao, Akira Yamamoto, Hiroki Kobayashi, Takumi Kondo, Keisuke Seike, Hideaki Fujiwara, Keiko Fujii, et al. [Treatment outcomes of axicabtagene ciloleucel for relapsed/refractory diffuse large B-cell lymphoma: a retrospective analysis at a single institution]. [Rinsho ketsueki] The Japanese journal of clinical hematology. 2025. 66. 2. 81-91
Kenta Hayashino, Wataru Kitamura, Nobuharu Fujii, Toshiki Terao, Hiroki Kobayashi, Chihiro Kamoi, Takumi Kondo, Keisuke Seike, Hideaki Fujiwara, Noboru Asada, et al. Severe hypophosphatemia following idecabtagene vicleucel regardless of the severity of cytokine release syndrome. Cytotherapy. 2025
Masaya Abe, Keiko Fujii, Nobuharu Fujii, Toshiharu Mitsuhashi, Takuya Fukumi, Yuichi Sumii, Maiko Kimura, Tomohiro Urata, Takumi Kondo, Fumio Otsuka, et al. Oral calcium supplementation versus placebo in mitigating citrate reactions during apheresis: an open-label randomized control trial. Hematology, Transfusion and Cell Therapy. 2024
Takumi Kondo, Keito Ohara, Shohei Yoshida, Kensuke Kojima. Development of disseminated intravascular coagulation in asymptomatic leukemic non-nodal mantle cell lymphoma. Annals of Hematology. 2024
藤井敬子, 藤井敬子, 藤井伸治, 藤井伸治, 三橋利晴, 住居優一, 住居優一, 谷勝真, 谷勝真, 浦田知宏, et al. Open-label, randomized study to calcium drink for prevention of citrate toxicity of PBSC donor. 日本造血・免疫細胞療法学会総会プログラム・抄録集. 2022. 45th
寺尾俊紀, 松岡賢市, 植田裕子, 松村彰文, 松原千哲, 近藤歌穂, 近藤匠, 藤原英晃, 淺田騰, 遠西大輔, et al. Gilteritinib maintenance therapy post-SCT improves the prognosis of patients with R/R FLT3mut AML. 日本造血・免疫細胞療法学会総会プログラム・抄録集. 2022. 45th